News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
269,358 Results
Type
Article (14285)
Company Profile (281)
Press Release (254792)
Multimedia
Podcasts (49)
Webinars (7)
Section
Business (79574)
Career Advice (153)
Deals (13237)
Drug Delivery (35)
Drug Development (50470)
Employer Resources (31)
FDA (5730)
Job Trends (5141)
News (144493)
Policy (10034)
Tag
Academia (916)
Accelerated approval (3)
Adcomms (13)
Allergies (52)
Alliances (21691)
ALS (69)
Alzheimer's disease (854)
Antibody-drug conjugate (ADC) (110)
Approvals (5757)
Artificial intelligence (134)
Autoimmune disease (19)
Automation (5)
Bankruptcy (105)
Best Places to Work (4560)
BIOSECURE Act (6)
Biosimilars (44)
Biotechnology (232)
Bladder cancer (61)
Brain cancer (20)
Breast cancer (165)
Cancer (1546)
Cardiovascular disease (122)
Career advice (134)
Career pathing (2)
CAR-T (127)
Cell therapy (349)
Cervical cancer (9)
Clinical research (41206)
Collaboration (568)
Compensation (285)
Complete response letters (13)
COVID-19 (1036)
CRISPR (47)
C-suite (173)
Cystic fibrosis (78)
Data (1652)
Denatured (11)
Depression (32)
Diabetes (146)
Diagnostics (1304)
Digital health (3)
Diversity (2)
Diversity, equity & inclusion (9)
Drug discovery (88)
Drug pricing (29)
Drug shortages (3)
Duchenne muscular dystrophy (95)
Earnings (30290)
Editorial (19)
Employer branding (4)
Employer resources (29)
Events (48877)
Executive appointments (478)
FDA (6518)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (9)
Funding (526)
Gene editing (105)
Generative AI (10)
Gene therapy (273)
GLP-1 (375)
Government (1084)
Grass and pollen (2)
Guidances (75)
Healthcare (6600)
Huntington's disease (23)
IgA nephropathy (26)
Immunology and inflammation (100)
Indications (20)
Infectious disease (1103)
Inflammatory bowel disease (119)
Inflation Reduction Act (8)
Influenza (20)
Intellectual property (68)
Interviews (18)
IPO (7282)
IRA (11)
Job creations (863)
Job search strategy (127)
Kidney cancer (7)
Labor market (8)
Layoffs (215)
Leadership (3)
Legal (1388)
Liver cancer (34)
Lung cancer (212)
Lymphoma (107)
Machine learning (5)
Management (7)
Manufacturing (148)
MASH (65)
Medical device (2610)
Medtech (2611)
Mergers & acquisitions (6299)
Metabolic disorders (416)
Multiple sclerosis (55)
NASH (13)
Neurodegenerative disease (78)
Neuropsychiatric disorders (26)
Neuroscience (1291)
NextGen: Class of 2025 (2021)
Non-profit (852)
Now hiring (23)
Obesity (201)
Opinion (103)
Ovarian cancer (67)
Pain (45)
Pancreatic cancer (60)
Parkinson's disease (126)
Partnered (8)
Patents (141)
Patient recruitment (85)
Peanut (35)
People (25713)
Pharmaceutical (47)
Pharmacy benefit managers (5)
Phase I (14564)
Phase II (19176)
Phase III (12101)
Pipeline (1007)
Policy (49)
Postmarket research (852)
Preclinical (6172)
Press Release (30)
Prostate cancer (64)
Psychedelics (35)
Radiopharmaceuticals (214)
Rare diseases (302)
Real estate (1419)
Recruiting (12)
Regulatory (8684)
Reports (18)
Research institute (938)
Resumes & cover letters (17)
Rett syndrome (5)
RNA editing (7)
RSV (10)
Schizophrenia (64)
Series A (103)
Series B (71)
Service/supplier (1)
Sickle cell disease (43)
Special edition (12)
Spinal muscular atrophy (117)
Sponsored (12)
Startups (1979)
State (1)
Stomach cancer (4)
Supply chain (23)
Tariffs (12)
The Weekly (37)
Vaccines (219)
Venture capitalists (32)
Weight loss (110)
Women's health (15)
Worklife (2)
Date
Today (116)
Last 7 days (590)
Last 30 days (2111)
Last 365 days (19385)
2025 (7480)
2024 (20556)
2023 (22416)
2022 (26831)
2021 (27807)
2020 (23356)
2019 (16228)
2018 (11745)
2017 (13746)
2016 (11842)
2015 (14350)
2014 (10393)
2013 (7485)
2012 (7532)
2011 (7621)
2010 (7431)
Location
Africa (148)
Alabama (44)
Alaska (2)
Arizona (53)
Arkansas (6)
Asia (17365)
Australia (2948)
California (4196)
Canada (1196)
China (379)
Colorado (160)
Connecticut (157)
Delaware (112)
Europe (37398)
Florida (510)
Georgia (128)
Idaho (16)
Illinois (245)
India (10)
Indiana (94)
Iowa (3)
Japan (83)
Kansas (64)
Kentucky (5)
Louisiana (4)
Maine (11)
Maryland (502)
Massachusetts (3324)
Michigan (77)
Minnesota (156)
Mississippi (1)
Missouri (24)
Montana (14)
Nebraska (4)
Nevada (17)
New Hampshire (14)
New Jersey (1024)
New Mexico (12)
New York (1112)
North Carolina (580)
North Dakota (6)
Northern California (1872)
Ohio (118)
Oklahoma (9)
Oregon (21)
Pennsylvania (784)
Puerto Rico (6)
Rhode Island (19)
South America (208)
South Carolina (5)
Southern California (1604)
Tennessee (26)
Texas (484)
United States (14247)
Utah (56)
Virginia (87)
Washington D.C. (32)
Washington State (370)
Wisconsin (19)
269,358 Results for "fulcrum therapeutics".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Fulcrum Therapeutics to Participate in Upcoming May 2025 Conferences
May 9, 2025
·
1 min read
Press Releases
Fulcrum Therapeutics Announces Recent Business Highlights and Financial Results for First Quarter 2025
May 2, 2025
·
9 min read
Press Releases
Fulcrum Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - May 9, 2025
May 12, 2025
·
1 min read
Press Releases
Fulcrum Therapeutics to Participate in the Leerink Partners Global Healthcare Conference
March 4, 2025
·
1 min read
Press Releases
Fulcrum Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - April 11, 2025
April 14, 2025
·
1 min read
Press Releases
Fulcrum Therapeutics to Host First Quarter 2025 Financial Results Conference Call and Webcast on Thursday, May 1, 2025, at 8:00 a.m. ET
April 25, 2025
·
1 min read
Press Releases
Fulcrum Therapeutics Announces Recent Business Highlights and Financial Results for Fourth Quarter and Full Year 2024
February 26, 2025
·
11 min read
Press Releases
Fulcrum Therapeutics to Participate in the Oppenheimer 35th Annual Healthcare Life Sciences Conference
February 6, 2025
·
1 min read
Press Releases
Fulcrum Therapeutics to Participate in Upcoming December Conferences
November 26, 2024
·
1 min read
Genetown
Fulcrum Therapeutics to Participate in Upcoming May Conferences
Fulcrum Therapeutics, Inc. today announced that management will participate in the following conferences: RBC Capital Market Global Healthcare Conference Wednesday May 15 at 4:05 p.m. ET.
May 9, 2024
·
1 min read
1 of 26,936
Next
